CDC vaccine meeting, delayed under RFK Jr., is rescheduled
The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...
Banks launch $8.1B debt sale, finance stake in Sanofi unit, Bloomberg says
Banks such as Goldman Sachs (GS) and Citigroup (C) have launched an EUR 7.45B, or $8.1B, debt sale to finance Clayton Dubilier & Rice’s ...
Sanofi initiated with a Neutral at Goldman Sachs
Goldman Sachs initiated coverage of Sanofi (SNY) with a Neutral rating and $65 price target While the firm sees Sanofi emerging as a pipeline ...
Goldman Sachs upgrades Sanofi (SNYNF) to a Hold
Goldman Sachs analyst James Quigley upgraded Sanofi (SNYNF – Research Report) to a Hold today and set a price target of €120.00. The company’s ...
Former Texas congressman Burgess eyed as CDC director nominee - report
The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...
U.S. boosts bird flu response with another $100M in funds
The U.S. Department of Agriculture (USDA) on Thursday announced a $100M investment to combat the transmission of the bird flu ...
Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal
Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with ...
PharmiWeb2d
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid ...
Wall Street Breakfast Podcast: March Madness Heats Up, Bets Roll In
Madness: Watch DraftKings, FanDuel, Robinhood, and Grand Canyon. CoreWeave seeks shares ranging from $47 to $55 in IPO:report ...
Sanofi to acquire Dren Bio’s DR-0201; deal includes $600M upfront payment
Sanofi (SNY) and Dren Bio, a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi has ...
Sanofi strikes autoimmune drug deal for up to $1.9B
Under the terms of the merger agreement, Sanofi will acquire DR-0201 through the acquisition of the Dren Bio affiliate ...
HighTower Advisors LLC Boosts Holdings in Sanofi (NASDAQ:SNY)
HighTower Advisors LLC increased its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The ...